OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trial
Mareike Aichholzer, Shiral S. Gangadin, Iris E. Sommer, et al.
Brain Behavior & Immunity - Health (2022) Vol. 26, pp. 100551-100551
Open Access | Times Cited: 8

Showing 8 citing articles:

Is It Time for a Paradigm Shift in the Treatment of Schizophrenia? The Use of Inflammation-Reducing and Neuroprotective Drugs—A Review
A. Messina, Carmen Concerto, Alessandro Rodolico, et al.
Brain Sciences (2023) Vol. 13, Iss. 6, pp. 957-957
Open Access | Times Cited: 22

Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial
Thomas W. Weickert, Isabella Jacomb, Rhoshel Lenroot, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 191-200
Open Access | Times Cited: 11

Reduced numbers of naïve CD4 + T cells and an altered CD4/CD8 balance in depressed common variable immune deficiency (CVID) patients. Is thymosin-α1 a possible treatment?
Olivia R. Manusama, Sajni Singh, Rik A. Brooimans, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110168-110168
Open Access | Times Cited: 5

Convergent impact of schizophrenia risk genes
PJ Michael Deans, Kayla G. Townsley, Aiqun Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8

Microglia and Other Cellular Mediators of Immunological Dysfunction in Schizophrenia: A Narrative Synthesis of Clinical Findings
Khoa D. Nguyen, Andrea Amerio, Andrea Aguglia, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2099-2099
Open Access | Times Cited: 3

Lack of Efficacy of Simvastatin Adjunctive Therapy for Patients with Schizophrenia: A Meta-Analysis of Randomized Controlled Trials
Junyu Chen, Yu‐Pei Yuan, Ying Hu, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 1667-1675
Open Access

O papel da imunidade na Esquizofrenia
Amanda Marçal Gonçalves, Clara Figueiredo Araújo, Davi Matioli Lopes, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 1, pp. 3401-3413
Open Access

Proinflammatory activity of monocytes and activity of glutathione-dependent enzymes in red blood cells in women with depressive conditions
E F Vasilyeva, О. К. Савушкина, T. A. Prokhorova, et al.
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 6, pp. 120-120
Closed Access

Page 1

Scroll to top